Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor for diabetic foot ulcers (Phase II)
CTR20170195Phase 2Completed
- Sponsor
- Staidson Biopharmaceutical
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mouse nerve growth factor in diabetic foot ulcer (DFU), sponsored by Staidson Biopharmaceutical. Started May 2017; status: completed.
02
Drugs
mouse nerve growth factor
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20170195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170195.